AliveCor’s Kardia 12L enters Vietnam, expanding access to faster heart checks and pushing digital cardiac care deeper into Southeast Asia.
Medical device and AI company AliveCor is taking another step into Southeast Asia, and this time, it’s bringing a more portable version of hospital-grade heart testing with it.
The company announced the regulatory registration of its Kardia 12L electrocardiogram (ECG) System, powered by KAI 12L AI technology, in Vietnam, opening the door for broader access to AI-enabled cardiac diagnostics in a country where cardiovascular disease remains a major public health burden [1].
In Vietnam, cardiovascular disease accounts for 33% of all deaths [2]. As hypertension, diabetes and urbanization-linked lifestyle shifts continue to rise, so too does the need for earlier, faster and more widely available heart screening.
For longevity-focused investors and operators, the significance goes beyond a product launch. This is a story about how modern healthcare is heading away from centralized, infrastructure-heavy systems, and toward smarter, lighter, more distributed diagnostics that can meet patients where they are.
At its core, AliveCor’s move into Vietnam is about access. Traditional 12-lead ECGs – the standard test used to capture the heart’s electrical activity and help identify serious issues – are often tied to larger clinical settings, more complex setups and hospital workflows that can slow things down when systems are under pressure.
AliveCor is positioning Kardia 12L as a more flexible alternative. A portable, AI-powered 12-lead ECG designed to deliver readings and interpretations highly similar to standard 12-lead systems, but directly at the point of care.
The company aims to give clinicians a quicker way to perform a full heart check without needing the patient to go through the more cumbersome setup many people associate with hospital-based ECGs.
Portability is especially relevant in Vietnam, where care is delivered across both dense urban centers and remote rural provinces. In that context, a tool that can travel and still provide meaningful clinical insight becomes more than a convenience.
One of the more practical details here may also be one of the most important. AliveCor says Kardia 12L uses a simplified five-electrode setup, reducing the complexity of the ECG process. Patients do not need to fully disrobe during a reading, making the experience less invasive, while clinicians can move more quickly from setup to result.
The company notes that research has shown nearly a 30% reduction in ECG acquisition time compared with standard 12-lead setups. In busy healthcare systems, shaving minutes off routine diagnostics can have an outsized impact. Faster readings can help clinicians confirm or rule out urgent problems sooner, improve triage and ease bottlenecks in hospitals already managing high patient volumes.
In other words, this is not just about AI as a shiny add-on. It is about workflow – arguably one of the least glamorous, but most consequential, drivers of better care.
AliveCor’s timing also aligns with Vietnam’s broader healthcare direction. The country’s Ministry of Health has prioritized digital transformation, hospital capacity optimization and expanded access to quality care, particularly outside major cities. Tools like Kardia 12L fit neatly into that agenda. Connected diagnostics that can support data-driven decision-making while extending more advanced clinical insight into frontline settings.
Moreover, AliveCor is not entering with a one-off device. The company frames Kardia 12L as part of a wider cardiovascular ecosystem that includes KardiaMobile and KardiaMobile 6L, suggesting a broader ambition to support the full heart-health pathway, from earlier screening to ongoing monitoring.
For the longevity sector, there is a bigger takeaway. Cardiovascular disease remains one of the most stubborn barriers to healthy aging. You can talk all you want about lifespan extension, but if people cannot access timely heart diagnostics, especially outside major medical centers, then the promise of longevity stays unevenly distributed.
AliveCor’s Vietnam expansion is a reminder that longevity sometimes looks like a faster ECG in a community clinic. Sometimes it looks like giving a clinician in a rural province the ability to spot trouble earlier.
With this, it is true that preventive, data-enabled care is being built in the real world, not only to help people live longer, but to give them a better chance of aging with fewer catastrophic interruptions.
Photograph courtesy of AliveCor
[1] https://www.globenewswire.com/news-release/2026/04/07/3269746/0/en/AliveCor-Expands-AI-Powered-12-lead-Cardiac-Diagnostics-to-Vietnam-Advancing-Access-to-Early-Detection-and-Modernized-Cardiac-Care.html
[2] https://hanoitimes.vn/treatment-abroad-no-longer-necessary-for-vietnamese-heart-patients-minister-of-health-325253.html
